Received: 4 January 2019
Accepted: 17 April 2019
First Online: 3 June 2019
Ethics approval and consent to participate
: The study was approved by the Regional Committee on Biomedical Research Ethics (case number: 1–10–72-332-15) and Danish Health and Medicines Authority (EudraCT number: 2015–002585-23). An informed, signed consent was obtained from each subject. The study was carried out in accordance with the Declaration of Helsinki and was monitored by the Good clinical practice-unit from Aarhus and Aalborg Universities.
: Not apllicable.
: All authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.